BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1366702)

  • 1. Human retinoblastoma susceptibility gene.
    Lai CC; Lee WH
    Genet Eng (N Y); 1990; 12():21-35. PubMed ID: 1366702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the human retinoblastoma susceptibility gene.
    Lee WH; Bookstein R; Lee EY
    J Cell Biochem; 1988 Nov; 38(3):213-27. PubMed ID: 3068232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
    Shew JY; Lin BT; Chen PL; Tseng BY; Yang-Feng TL; Lee WH
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):6-10. PubMed ID: 1688660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas.
    Shew JY; Ling N; Yang XM; Fodstad O; Lee WH
    Oncogene Res; 1989; 4(3):205-14. PubMed ID: 2740144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of retinoblastoma.
    Goodrich DW; Lee WH
    Cancer Surv; 1990; 9(3):529-54. PubMed ID: 2101724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB1 germ-line deletions in Argentine retinoblastoma patients.
    Fernández C; Repetto K; Dalamon V; Bergonzi F; Ferreiro V; Szijan I
    Mol Diagn Ther; 2007; 11(1):55-61. PubMed ID: 17286450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the retinoblastoma susceptibility gene.
    Goodrich DW; Lee WH
    Biochim Biophys Acta; 1993 May; 1155(1):43-61. PubMed ID: 8504130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
    Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
    Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations.
    Hu QJ; Dyson N; Harlow E
    EMBO J; 1990 Apr; 9(4):1147-55. PubMed ID: 2138977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human retinoblastoma gene product pp110RB in insect cells using the baculovirus system.
    Wang NP; Qian YW; Chung AE; Lee WH; Lee EY
    Cell Growth Differ; 1990 Sep; 1(9):429-37. PubMed ID: 2288881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.
    Huang S; Wang NP; Tseng BY; Lee WH; Lee EH
    EMBO J; 1990 Jun; 9(6):1815-22. PubMed ID: 2189724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new model of tumor susceptibility following tumor suppressor gene inactivation.
    Ajioka I; Dyer MA
    Cell Cycle; 2008 Mar; 7(6):735-40. PubMed ID: 18239449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reintroduction of a normal retinoblastoma gene into retinoblastoma and osteosarcoma cells inhibits the replication associated function of SV40 large T antigen.
    Uzvolgyi E; Classon M; Henriksson M; Huang HJ; Szekely L; Lee WH; Klein G; Sumegi J
    Cell Growth Differ; 1991 Jun; 2(6):297-303. PubMed ID: 2064998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the retinoblastoma susceptibility gene in human breast cancers.
    Lee EY; To H; Shew JY; Bookstein R; Scully P; Lee WH
    Science; 1988 Jul; 241(4862):218-21. PubMed ID: 3388033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of human c-fos expression by the retinoblastoma gene product.
    Robbins PD; Horowitz JM; Mulligan RC
    Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice.
    Sumegi J; Uzvolgyi E; Klein G
    Cell Growth Differ; 1990 May; 1(5):247-50. PubMed ID: 1964797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
    Vooijs M; te Riele H; van der Valk M; Berns A
    Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p107 is a suppressor of retinoblastoma development in pRb-deficient mice.
    Robanus-Maandag E; Dekker M; van der Valk M; Carrozza ML; Jeanny JC; Dannenberg JH; Berns A; te Riele H
    Genes Dev; 1998 Jun; 12(11):1599-609. PubMed ID: 9620848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutational inactivation of the retinoblastoma antioncogene.
    Horowitz JM; Yandell DW; Park SH; Canning S; Whyte P; Buchkovich K; Harlow E; Weinberg RA; Dryja TP
    Science; 1989 Feb; 243(4893):937-40. PubMed ID: 2521957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.